英格兰1型和2型糖尿病与COVID-19相关死亡率的关联:全人群研究
该全人群研究纳入2020年3月1日至5月11日英格兰全科登记且2020年2月16日存活者,采用多变量logistic回归分析糖尿病类型与COVID-19住院死亡的关系。结果显示,调整年龄、性别、贫困、族裔和地理区域后,1型糖尿病OR为3.51(95%CI 3.16-3.90),2型糖尿病OR为2.03(95%CI 1.97-2.09);进一步调整冠心病、脑血管病或心衰住院史后OR分别衰减至2.86(2.58-3.18)和1.80(1.75-1.86)。
要点
- 研究期间共发生23 698例COVID-19住院死亡,其中31.4%为2型糖尿病、1.5%为1型糖尿病、0.3%为其他类型糖尿病。
- 未调整每10万人72天死亡率:无糖尿病27(95%CI 27-28)、1型糖尿病138(124-153)、2型糖尿病260(254-265)。
- 调整年龄、性别、贫困、族裔和地理区域后,1型糖尿病OR 3.51(3.16-3.90)、2型糖尿病OR 2.03(1.97-2.09)。
核心结论
- 英格兰全国性分析显示,1型和2型糖尿病均与COVID-19住院死亡几率显著增加独立相关。
研究设计与样本
- 全人群研究,纳入2020年2月16日存活且登记于英格兰全科诊所的全部个体,观察2020年3月1日至5月11日。
- 采用多变量logistic回归分析糖尿病类型对COVID-19住院死亡的影响,调整人口学因素和心血管合并症。
- 因缺乏观察期间COVID-19总感染人数数据,计算全人群死亡率而非感染人群死亡率。
主要发现
- 61 414 470名登记个体中,263 830人(0.4%)有1型糖尿病诊断记录,2 864 670人(4.7%)有2型糖尿病诊断记录,41 750人(0.1%)有其他类型糖尿病,58 244 220人(94.8%)无糖尿病。
- 研究期间发生23 698例COVID-19住院死亡,其中2型糖尿病7 434例(31.4%)、1型糖尿病364例(1.5%)、其他类型糖尿病69例(0.3%)。
- 未调整每10万人72天死亡率:无糖尿病27(95%CI 27-28),1型糖尿病138(95%CI 124-153),2型糖尿病260(95%CI 254-265)。
- 调整年龄、性别、贫困、族裔和地理区域后,相比无糖尿病者,1型糖尿病住院COVID-19相关死亡OR为3.51(95%CI 3.16-3.90),2型糖尿病OR为2.03(95%CI 1.97-2.09)。
- 进一步调整冠心病、脑血管病或心衰既往住院史后,OR衰减至1型糖尿病2.86(95%CI 2.58-3.18)、2型糖尿病1.80(95%CI 1.75-1.86)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although diabetes has been associated with COVID-19-related mortality, the absolute and relative risks for type 1 and type 2 diabetes are unknown. We assessed the independent effects of diabetes status, by type, on in-hospital death in England in patients with COVID-19 during the period from March 1 to May 11, 2020. METHODS: We did a whole-population study assessing risks of in-hospital death with COVID-19 between March 1 and May 11, 2020. We included all individuals registered with a general practice in England who were alive on Feb 16, 2020. We used multivariable logistic regression to examine the effect of diabetes status, by type, on in-hospital death with COVID-19, adjusting for demographic factors and cardiovascular comorbidities. Because of the absence of data on total numbers of people infected with COVID-19 during the observation period, we calculated mortality rates for the population as a whole, rather than the population who were infected. FINDINGS: Of the 61 414 470 individuals who were alive and registered with a general practice on Feb 16, 2020, 263 830 (0·4%) had a recorded diagnosis of type 1 diabetes, 2 864 670 (4·7%) had a diagnosis of type 2 diabetes, 41 750 (0·1%) had other types of diabetes, and 58 244 220 (94·8%) had no diabetes. 23 698 in-hospital COVID-19-related deaths occurred during the study period. A third occurred in people with diabetes: 7434 (31·4%) in people with type 2 diabetes, 364 (1·5%) in those with type 1 diabetes, and 69 (0·3%) in people with other types of diabetes. Unadjusted mortality rates per 100 000 people over the 72-day period were 27 (95% CI 27-28) for those without diabetes, 138 (124-153) for those with type 1 diabetes, and 260 (254-265) for those with type 2 diabetes. Adjusted for age, sex, deprivation, ethnicity, and geographical region, compared with people without diabetes, the odds ratios (ORs) for in-hospital COVID-19-related death were 3·51 (95% CI 3·16-3·90) in people with type 1 diabetes and 2·03 (1·97-2·09) in people with type 2 diabetes. These effects were attenuated to ORs of 2·86 (2·58-3·18) for type 1 diabetes and 1·80 (1·75-1·86) for type 2 diabetes when also adjusted for previous hospital admissions with coronary heart disease, cerebrovascular disease, or heart failure. INTERPRETATION: The results of this nationwide analysis in England show that type 1 and type 2 diabetes were both independently associated with a significant increased odds of in-hospital death with COVID-19. FUNDING: None.
引用
- Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020. PMID: 32798472. doi:10.1016/S2213-8587(20)30272-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。